Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1977 Jul 9;2(6079):94–96. doi: 10.1136/bmj.2.6079.94

Disulfiram hepatotoxicity.

L Ranek, P Buch Andreasen
PMCID: PMC1630947  PMID: 871808

Full text

PDF
94

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eisen H. J., Ginsberg A. L. Letter: Disulfiram hepatotoxicity. Ann Intern Med. 1975 Nov;83(5):673–675. doi: 10.7326/0003-4819-83-5-673_2. [DOI] [PubMed] [Google Scholar]
  2. Keeffe E. B., Smith F. W. Disulfiram hypersensitivity hepatitis. JAMA. 1974 Oct 21;230(3):435–436. [PubMed] [Google Scholar]
  3. Maddrey W. C., Boitnott J. K. Isoniazid hepatitis. Ann Intern Med. 1973 Jul;79(1):1–12. doi: 10.7326/0003-4819-79-1-1. [DOI] [PubMed] [Google Scholar]
  4. Reynolds T. B., Peters R. L., Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971 Oct 7;285(15):813–820. doi: 10.1056/NEJM197110072851501. [DOI] [PubMed] [Google Scholar]
  5. Rodman J. S., Deutsch D. J., Gutman S. I. Methyldopa Hepatitis. A report of six cases and review of the literature. Am J Med. 1976 Jun;60(7):941–948. doi: 10.1016/0002-9343(76)90564-7. [DOI] [PubMed] [Google Scholar]
  6. STROMME J. H. Inhibition of hexokinase by disulfiram and diethyldithiocarbamate. Biochem Pharmacol. 1963 Feb;12:157–166. doi: 10.1016/0006-2952(63)90180-1. [DOI] [PubMed] [Google Scholar]
  7. Stripp B., Greene F. E., Gillette J. R. Disulfiram impairment of drug metabolism by rat liver microsomes. J Pharmacol Exp Ther. 1969 Dec;170(2):347–354. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES